Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam

Neuropsychopharmacology

Volumn 18, Issue 5, 1998, Pages 364-369

  Furukori, Hanako ^a   Otani, Koichi ^b   Yasui, Norio ^a   Kondo, Tsuyoshi ^a   Kaneko, Sunao ^a   Shimoyama, Ritsuko ^a   Ohkubo, Tadashi ^a   Nagasaki, Takako ^a   Sugawara, Kazunobu ^a  

^a HIROSAKI UNIVERSITY HOSPITAL   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Alprazolam; Carbamazepine; CYP3A4; Metabolism; Pharmacokinetics; Single oral dose

Indexed keywords

ALPRAZOLAM; CARBAMAZEPINE; CYTOCHROME P450 ISOENZYME; ENZYME INDUCING AGENT; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEDATION; VOLUNTEER;

ADULT; ALPRAZOLAM; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; CARBAMAZEPINE; DOUBLE-BLIND METHOD; HALF-LIFE; HUMANS; MALE; MOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE;

EID: 0031935923     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00166-8     Document Type: Article

References (26)

1. Albani F, Riva R, Baruzzi A Carbamazepine clinical pharmacology. A review Pharmacopsychiatry. 28:1995;235-244.
2. Arana GW, Goff DC, Friedman H, Ornsteen M, Greenblatt DJ, Black B, Shader RI Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms? Am J Psychiatry. 143:1986;650-651.
3. Arana GW, Epstein S, Molloy M, Greenblatt DJ Carbamazepine-induced reduction of plasma alprazolam concentrations. A clinical case report J Clin Psychiatry. 49:1988;448-449.
4. Backman JT, Olkkola KT, Ojala M, Laaksovirta H, Neuvonen PJ Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin. Epilepsia. 37:1996;253-257.
5. Bertilsson L, Tomson T Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update. Clin Pharmacokinet. 11:1986;177-198.
6. Bertilsson L, A-Wistedt A, Liden A, Otani K, Spina E Alprazolam does not inhibit the metabolism of nortriptyline in depressed patients or inhibit the metabolism of desipramine in human liver microsomes. Ther Drug Monit. 10:1988;213-223.
7. Greenblatt DJ, Shader RI, Harmatz JS, Franke K, Koch-Weser J Absorption rate, blood concentrations, and early response to oral chlordiazepoxide. Am J Psychiatr. 134:1977;559-562.
8. Greenblatt DJ, Wright CE Clinical pharmacokinetics of alprazolam. Therapeutic implications. Clin Pharmacokinet. 24:1993;453-471.
9. Kerr BM, Thummel KE, Wurden CJ, Klein SM, Kroets DL, Gonzalez FJ, Levy RH Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol. 47:1994;1969-1979.
10. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand. 76(suppl 334):1987;11-100.
11. Nagasaki T, Ohkubo T, Sugawara K, Yasui N, Otani K, Kanetko S Determination of alprazolam and α-hydroxyalprazolam in plasma by high-performance liquid chromatography. Anal Sci. 13:1997;245-249.
12. Olkkola KT, Aranko K, Luurila H, Hiller A, Saarnivaara L, Himberg JJ, Neuvonen PJ A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther. 53:1993;298-305.
13. Olkkola KT, Backman JT, Neuvonen PJ Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole. Clin Pharmacol Ther. 55:1994;481-485.
14. Otani K, Yasui N, Kaneko S, Ohkubo T, Osanai T, Sugawara K Carbamazepine augmentation therapy in three patients with trazodone-resistant unipolar depression. Int Clin Psychopharmacol. 11:1996;55-57.
15. Otani K, Ishida M, Kaneko S, Mihara K, Ohkubo T, Osanai T, Sugawara K Effects of carbamazepine coadministration on plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine. Ther Drug Monit. 18:1996;164-167.
16. Otani K, Yasui N, Kaneko S, Ohkubo T, Osanai T, Sugawara K, Hayashi K, Chiba K, Ishizaki T Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam. Neuropsychopharmacology. 16:1997;8-14.
17. Otani K, Ishida M, Yasui N, Kondo T, Mihara K, Suzuki A, Furukori H, Kaneko S, Inoue Y Interaction between carbamazepine and bromperidol. Eur J Clin Pharmacol. 52:1997;219-222.
18. Paine MF, Shen DD, Kunze KL, Perkins JD, Marsh CL, McVicar JP, Barr DM, Gillies BS, Thummel KE First-pass metabolism of midazolam by the human intestine. Clin Pharmacol Ther. 60:1996;14-24.
19. Pirmohamed M, Allott R, Green VJ, Kitteringham NR, Chadwick D, Park BK Lymphocyte microsomal epoxide hydrolase in patients on carbamazepine therapy. Br J Clin Pharmacol. 37:1994;577-581.
20. Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, Marangell L, George MS Anticonvulsants in refractory mood disorders. Nolen WA, Zohar J, Roose SP, Amsterdam JD Refractory Depression. Current Strategies and Future Directions:1994;97-114 U.K, Chichester. John Wiley.
21. Siris SG Adjunctive medication in the maintenance treatment of schizophrenia and its conceptual implications. Br J Psychiatry. 163:1993;66-78.
22. von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Harmatz JS, Shader R Inhibitors of alprazolam metabolism in vitro. Effect of serotonin-reuptake-inhibitor antidepressants, ketokonazole and quinidine Br J Clin Pharmacol. 38:1994;23-31.
23. Watkins PB Noninvasive tests of CYP3A enzymes. Pharmacogenetics. 4:1994;171-184.
24. Wietholtz H, Zysset T, Kreiten K, Kohl D, Buchsel R, Matern S Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism. Eur J Clin Pharmacol. 36:1989;401-406.
25. Yasui N, Otani K, Kaneko S, Ohkubo T, Osanai T, Sugawara K, Chiba K, Ishizaki T A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans. In vivo evidence for the involvement of CYP3A4 in alprazolam metabolism Clin Pharmacol Ther. 59:1996;514-519.
26. Yue QY, Tomson T, Sawe J Carbamazepine and cigarette smoking induce differentially the metabolism of codeine in man. Pharmacogenetics. 4:1994;193-198.